Clinical Trial Update: Post Marketing Surveillance Study To Observe Safety And Efficacy Of Eraxis® IV

View source ↗

Summary

A post-marketing surveillance study assessing the safety and efficacy of Eraxis IV in candidemia and other Candida infections completed with results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candida Infections Such As Intra-abdominal Abscess and Peritonitis
• Candidemia

Drugs mentioned

• Eraxis (anidulafungin)

Snippet

Sponsor: Pfizer | Conditions: Candidemia, Other Forms of Candida Infections(Intra-abdominal Abscess, Peritonitis) | Status: COMPLETED | Results posted: 2017-11-30